Dr Peter Fish
CEO
Peter is a medical doctor with a degree in Human Genetics and an MBA. He has previously founded and managed a number of tech, healthtech and biotech companies and organisations, many of which focused on scalable mechanisms for delivering stratified and personalised medicine. He joined Mendelian as an early investor and assisted the founders from an early stage. He stepped into the CEO role in March 2022.
Rudy Benfredj
Advisor, Co-Founder
Rudy is a French Computer Scientist. He graduated from Imperial College London with a degree in Computing Engineering during which he worked under the supervision of Dr. Aldo Faisal in the bioengineering department. Passionate about health, he then moved to Tel Aviv to work at the Israeli medtech company Healthy.io focused on remote diagnosis as a software engineer and then as a Product Manager where he helped the team grow from 4 to 20 under 12 months. That same year, he set up and curated the first TEDMED event in London. He then pursued a course on impactful problem solving as the youngest graduate at Singularity University at NASA Ames.
Fran Garcia
Non-Executive Chairman, Co-Founder
Fran is a Spanish Industrial Engineer and business professional who started his career in Sales and Marketing Consulting in Pharma. After completing his MBA, he enrolled in the Corporate Finance practice of a global strategy firm where he conducted engagements across Europe for both industrial conglomerates and private equity investors. He then jumped at the opportunity to manage the Finance & Administration function at the Spanish start-up of a large UK car insurer, which enticed him to kickstart his own entrepreneurial journey. Over the past decade, Fran has been involved as a Founder or Seed investor in multiple successful B2C and B2B ventures, leading functions as diverse as Marketing, Technology and Governance. Fran met his Mendelian co-founders at Singularity University's GSP program at NASA Ames in 2014.
Dr Ignacio Hernandez Medrano
Clinical Advisor, Co-Founder
Dr Ignacio was awarded "Digital health personality of 2017" in Spain. He is a Spanish practicing Neurologist with strong interest in Genetics and Healthcare systemic changes. His background comprises Healthcare Management and Public Health Administration in the biggest health institutions in Spain. Nacho was Head of Strategy of the Ramon y Cajal Health Research Institute. He joined Mendelian as Chief Scientist while graduating from the GSP program at Singularity University at NASA Ames in 2014.
Dr Will Evans
Clinical Advisor
Dr Will Evans is a clinical advisor at Mendelian and a practicing GP and academic. Will graduated from the University of Leeds MBChB in 2002 and works as a GP in Leeds. He completed an MSc in Genomic Medicine with distinction from the University of Manchester in 2018. Will holds an NIHR in practice fellowship award (Oct 2018 – April 2021) and works part time with the PRISM research group at the University of Nottingham. His research interests involve personalised medicine, rare diseases, genomics in Primary Care and large database analysis. Will’s eldest son Sam has Niemann-Pick type C, an ultra rare metabolic disease and Will is actively involved in the NPC community.
Dr Alan Warren
Lead Engineer
After graduating with a degree in Physics from Portsmouth University and a PhD in Physics from the University of Newcastle upon Tyne, Alan took up research fellowships with universities and industry, where he developed computer simulations of magnetisation processes in magnetic storage media. Later, he transferred into the IT industry as a software developer. He has worked for many organisations, both private and public sector, in the UK and abroad.
Hadley Mahon
Chief Business Officer
Hadley has spent her career working towards smarter, more effective healthcare. As a senior leader at Pfizer, she worked across the rare disease & oncology portfolio building an expertise in developing new therapies and bringing them to market around the world. As the Head of Commercial & Partnerships at Mendelian Health, Hadley is furthering her passion for serving rare disease patients by ensuring they are never lost in the healthcare system. Hadley holds an MBA from The Stern School of Business, New York University and a BA from Columbia University. A lifelong New Yorker, she, along with her family, is giving life in London a go.
Jez Stockdale
Strategy Advisor
Jez graduated from Oxford University with a degree in Philosophy, Politics and Economics. After working as an economist across several government departments, he discovered a passion for healthcare in HM Treasury while working as a Senior Adviser to the Chancellor on NHS funding and policy. He moved from government to work for Kamet, a start-up studio, where he spent three years building health technology start-ups. Outside of work, he is a trustee for Headway East London - a charity supporting brain injury survivors and their families.
Freya Boardman-Pretty
Data Scientist
Freya graduated with a degree in Biology from the University of York, after which she moved to UCL to complete an MSc in Genetics of Human Disease and a PhD in cardiovascular genetics. After joining StoreGene, where she developed algorithms and patient reports for cardiovascular risk, she worked at Genomics England managing a rare disease research community working on the 100,000 Genomes Project data. Now combining her interests in rare diseases and in using data to improve health, at Mendelian she works as a data scientist, using health data to find new ways to detect and investigate rare diseases.
Chanaka Ranawickrema
Business Development Manager
Chanaka has over 20 years experience in the Healthcare industry. He graduated from King's College, London with a BSc in Molecular Biology and went on to work in various business development roles for some of the leading Pharma and private healthcare companies. Chanaka has since specialised in the Digital Healthcare sector working for large clinical system providers such as EMIS and as an independent consultant to a number of digital start-ups. He is also completing an MBA in Strategic Health and Social Care from Manchester Met University. Chanaka is hoping to combine his passions for digital health and genetics at Mendelian to make a true difference for those patients with rare diseases.
Amanda Worker
Data Scientist
Amanda is a Data Scientist and is responsible for harnessing the power of predictive analytics for rare disease detection. She studied Cognitive Science as an undergraduate before completing an MSc and PhD in Neuroimaging at The Institute of Psychiatry, Psychology and Neuroscience, King’s College London. Amanda specialised in using Magnetic Resonance Imaging (MRI) and cardiovascular risk factors to identify early markers of neurodegenerative disease. She then continued her work with King’s College London as a post-doctoral researcher applying statistical and machine learning techniques to identify individual clinical risk profiles for individuals experiencing psychosis.
Jack Sams
DevOps Engineer
Jack is a Development Operations Engineer with 2.5 years experience in health-tech companies with a focus on rare disease. He graduated from the University of the West of England with a degree in Software Engineering for Business. He worked to support the development of a decision engine on behalf of NHS Digital & Genomics England. The project utilised data from the 100,000 Genomes Project, an initiative to sequence the genomes of NHS patients with a rare disease and their families to provide faster and more accurate diagnosis. He is now working to maintain and improve technical infrastructure and cloud security at Mendelian.
Daniel Ollerenshaw
Software Engineer
Daniel is a software engineer with 3 years experience, specialising in the python language. He graduated from Durham University with a degree in Economics.
Elena Marchini
Product Manager
Elena is a Biomedical Engineer and has spent her career in the healthcare IT industry. She is an expert in administrative and clinical functionalities of Hospital Information Systems. She has delivered many successful projects both in the UK and abroad. Elena is passionate about healthtech and strongly believes in its enormous potential to transform and improve patient care.
Elizabeth Varones
Head of Industry Partnerships
Liz Varones is a seasoned marketing and sales leader and the Head of Industry Partnerships at Mendelian. While at Pfizer, she sold and marketed numerous blockbuster pharmaceuticals and vaccines in the US and global markets. Liz has led numerous transformation initiatives that helped drive new solutions for customers (predictive model for chronic pain conditions), marketing capabilities (key account management, digital), and ways of working (content management platform, portfolio storytelling). Before joining Mendelian, she managed a marketing consultancy focused on brand identity development, positioning, and communications.
Calum Grant
Clinician & Data Scientist
Calum is a physics and medicine graduate with four years experience working as a medical doctor. He graduated with a Masters degree in Physics from the University of Durham, before going on to pursue his Medical Degree at the University of Warwick. He completed his medical foundation training in London, whilst also undertaking a Data Science internship at a tech startup. Currently working as a Data Scientist and Clinician at Mendelian, he leverages his diverse background to expedite the diagnosis of rare and challenging diseases. Simultaneously, he explores the potential integration of these technologies into health systems, assessing their probable resource impacts.
Rand Dubis
Data Scientist
Rand graduated with a master's degree in molecular biology from Lund University in Sweden. She relocated to London, where she held various roles in academia and industry within the diagnostic field. Developing a keen interest in genetics during this time, she transitioned into clinical genetics, initially focusing on diagnostics within the NHS. Later, she joined Congenica Ltd, working in rare disease. Her curiosity about the analytical processes in clinical genetics prompted her to pursue a master's degree in data science at the University of London. As a data scientist at Mendelian, she combines her interest in rare disease and data science to contribute to the improvement of healthcare for rare disease patients.
